drugset / Trial / NCT03976206
Very Small Embryonic-like Stem Cells for Facial Skin Antiaging
Phase 1/2
Withdrawn
Fuda Cancer Hospital, Guangzhou
Guangzhou Four-Leaf Clover HealthTech Co., Ltd. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to facial skin antiaging.
Timeline
- Start
- 2019-07-06
- Primary completion
- 2020-05-20
- Completion
- 2020-07-01
Outcome
Outcome not reported
Stopped: “Policy changes have contributed to the failure to carry out smoothly”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | very small embryonic-like stem cell | Cell therapy | 0.4 ml | Other |
| Subject | very small embryonic-like stem cell | Cell therapy | 30000 cells | Other |
| Subject | very small embryonic-like stem cell | Cell therapy | 60000 cells | Other |
| Subject | very small embryonic-like stem cell | Cell therapy | 90000 cells | Other |